The long-awaited alternative

Our team of scientists developed a new peptide—the Intide™—and a new way to deliver it—the multiphasic vesicle—that makes it possible, for the first time ever, to deliver on the precision of needles and lasers, without them.
image description



It starts with the Intide™


We’ve developed the first-ever Intide™—intelligent, innate, innovative, patent-pending peptides—that naturally target and deliver results right where it matters, leaving your skin firmer and smoother than ever before.

image description



Delivered through a Multiphasic Vesicle


Our exclusive multiphasic vesicle delivers Intides™ to specific areas of the skin with accuracy and is made out of resources naturally found in your body, such as collagen and elastin. This helps gently restore your skin and leave you feeling and looking like yourself.

Going where no skincare has gone before

treatment areas

Hyperpigmentation

Fine Lines & Wrinkles

Hyperpigmentation

Our patent-pending Brightening Intides™–Intelligent Peptides–help target and eliminate dark spots before they even begin. Niacinamide and vitamin c also work to improve your skin’s tone for a brighter, more even-toned complexion.

Shop Now
Daily Dark Spot Intercept
with Subtopical Brightening Technology™
$260
shop
image description
Lips

Our Subtopical Plumping Technology™ works to infuse hyaluronic acid to reclaim volume, suppleness, and definition, and to enhance the color of your lips. Enjoy fuller, natural-looking lips without injections.

Shop Now
The Lip Plumping and Enhancing Regimen
Intensive Filling & Smoothing Duo
$180 $190
shop
image description
Fine Lines & Wrinkles

Stay tuned, coming soon.

treatment areas

Founded by disruptors

We knew that if we wanted to create a new category of skincare we had to create new technology. Our team of biochemists, engineers, and doctors worked together to create a subtopical technology that's never been seen in skincare before.

  • image description

    Vimla Black-Gupta

    Co-Founder and Chief Executive Officer

    Vimla Black Gupta is a Co-Founder and President of Ourself, who brings more than 25 years of marketing leadership to the role. Most recently, Vimla served as Chief Marketing Officer of Equinox, where she oversaw the company’s global marketing strategy and developed unique campaigns that elevated its positioning from a fitness company to a lifestyle brand. Prior, she spent 10 years at The Estee Lauder Companies and held the position of Senior Vice President of Global Marketing at Bobbi Brown Cosmetics, where she grew the brand to a $1B business across 150 countries. She also spent a decade at Procter & Gamble, where she oversaw the strategic positioning and new product and category development for Gillette’s Venus brand as Global Marketing Director. 

  • image description

    Lauren Otsuki, M.Sc

    Co-Founder, Executive Vice President, and Chief Innovation Officer

    Lauren Otsuki is the Co-Founder, Executive Vice President, and Chief Innovation Officer of Ourself and its parent company, GLO Pharma. Lauren has founded and managed five successful biotech firms, DexCom, NovaCardia, Oncternal Therapeutics, Alastin Skincare, and Prometheus Biosciences, where she was responsible for development and operations. She has played an integral role in implementing scientific research and development into skincare product formulation with leading professional skincare companies like SkinMedica and Alastin Skincare, and now in aesthetics with Ourself and GLO Pharma.

  • image description

    Scott Glenn

    Co-Founder and Chairman

    Scott Glenn is the Co-Founder and Chairman of Ourself and its parent company GLO Pharma.  A serial entrepreneur, who seeks solutions to the medical industry’s toughest challenges, Scott has developed and advanced numerous therapeutics, devices, and diagnostics aimed at addressing a range of medical conditions including cancer, diabetes, and autoimmune diseases. Over the last 20 years, he has founded and managed over 25 successful biotech companies including Quidel and Prometheus Labs and pioneered two professional skincare brands, Alastin Skincare and SkinMedica. 

developed by a team experts

  • image description

    Robert Love, Ph.D.

    Principal Scientist

    Robert Love is the Co-Founder and Principal Scientist of Ourself and GLO Pharma. A highly specialized, formally trained scientist, Robert has an established career in protein x-ray crystallography and his innovations have applications to immunology, antiviral and oncology targets. His extensive experience in structure-based drug design ranges from small molecules to peptidic therapeutics. Robert has decades of experience with companies like Agouron, Pfizer, Oncternal Therapeutics. He brings Ourself’s position of direct-to-consumer aesthetics to a next-generation level with patented peptides and biotechnology that rivals in office procedures safely at home.

  • image description

    Tina Fleck

    Vice President of Research and Development

    Tina Fleck is the Senior Director of Research and Development of Ourself. Tina has over 20 years of experience in the cosmetic industry in formulation,  manufacturing scale-up, regulatory, quality control, clinical and marketing support.  Past employers include Allergan/SkinMedica, and SENTE.

  • image description

    Kara Pennington PA-C, MMS

    Head of Clinical Research Operations

    Kara Pennington is the Head of Clinical Research Operations and In-House Medical Aesthetics Expert of Ourself. Most recently, Kara practiced as a Physician Assistant at the La Jolla Cosmetic Surgery Centre and Medical Spa, where she developed and administered treatment plans tailored to each patient's individual goals, inclusive of filler, wrinkle relaxers, or laser treatments. Kara received her Master's Degree in Medical Science from the Stanford University School of Medicine and discovered her calling for plastic surgery and aesthetics in her final year of school after completing an elective clinical internship in the field. She is passionate about educating her patients about the natural aging process and guiding them toward treatment plans that best suit their needs.

  • image description

    Eva Simmons-O’Brien, M.D., F.A.A.D.

    Medical Advisor

    Dr. Eva Simmons-O’Brien is a board certified dermatologist and an Assistant Professor of Internal Medicine at the Johns Hopkins University School of Medicine. She received her undergraduate degree from Dartmouth College and her medical degree from Yale University in 1988 where she graduated Cum Laude and was inducted to the Alpha Omega Honor Society. She completed residency training in both medicine and dermatology at the Johns Hopkins Hospital, where she also served as full time faculty for both departments from 1993-1998. In 1999 Dr. Simmons-O’Brien entered private dermatology practice. Dr. Simmons-O’Brien is a Fellow of the American Academy of Dermatology, a member of the American Society for Dermatologic Surgery and the Women’s Dermatologic Society. She has also served as a consultant to the dermatologic and ophthalmic division of the Food and Drug Administration, as well as Vice Chair of the Dermatology Foundation.

  • image description

    Diane Orlinsky, M.D., F.A.A.D.

    Medical Advisor

    Dr. Diane Orlinsky is a board certified dermatologist and an Assistant Professor of Internal Medicine at the Johns Hopkins University School of Medicine. She received her undergraduate degree from Columbia College, Cum Laude, and her medical degree with honors from the Johns Hopkins University School of Medicine. She completed residency training in both internal medicine and dermatology at the Johns Hopkins Hospital. Dr. Orlinsky is a Fellow of the American Academy of Dermatology, and is a member of the American Society for Dermatologic Surgery and the Alpha Omega Alpha Honor Society. She has served as the Alpha Omega Alpha Councilor for the Johns Hopkins University School of Medicine and Vice-Chair for the Maryland chapter of the Dermatology Foundation. Currently, she is the President of the Johns Hopkins Medical and Surgical Alumni Association, and a member of the Columbia College Women’s Board